2016-06-08 13:14 CEST (GLOBE NEWSWIRE) — The first 100 cases constitute a milestone for Episurf. The fact that we can now also compile good clinical follow-up data reflects in the increasing demand for the technology. After 3.5 years, there has not been a single revision, which is quite unprecedented in the field” comments Dr Leif […]

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone